Arizona State Retirement System’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12.4M | Buy |
37,928
+680
| +2% | +$222K | 0.07% | 240 |
|
2025
Q1 | $10.1M | Buy |
37,248
+44
| +0.1% | +$11.9K | 0.06% | 258 |
|
2024
Q4 | $8.75M | Buy |
37,204
+964
| +3% | +$227K | 0.05% | 300 |
|
2024
Q3 | $9.97M | Buy |
36,240
+1,504
| +4% | +$414K | 0.06% | 275 |
|
2024
Q2 | $8.44M | Buy |
34,736
+219
| +0.6% | +$53.2K | 0.06% | 286 |
|
2024
Q1 | $5.16M | Buy |
34,517
+161
| +0.5% | +$24.1K | 0.04% | 398 |
|
2023
Q4 | $6.58M | Buy |
34,356
+383
| +1% | +$73.3K | 0.05% | 326 |
|
2023
Q3 | $6.02M | Buy |
33,973
+153
| +0.5% | +$27.1K | 0.05% | 323 |
|
2023
Q2 | $6.42M | Sell |
33,820
-1,947
| -5% | -$370K | 0.05% | 327 |
|
2023
Q1 | $7.16M | Buy |
35,767
+1,793
| +5% | +$359K | 0.06% | 300 |
|
2022
Q4 | $8.07M | Buy |
33,974
+803
| +2% | +$191K | 0.08% | 255 |
|
2022
Q3 | $6.64M | Sell |
33,171
-379
| -1% | -$75.9K | 0.07% | 274 |
|
2022
Q2 | $4.89M | Buy |
33,550
+258
| +0.8% | +$37.6K | 0.05% | 360 |
|
2022
Q1 | $5.44M | Buy |
33,292
+933
| +3% | +$152K | 0.04% | 378 |
|
2021
Q4 | $5.49M | Sell |
32,359
-629
| -2% | -$107K | 0.04% | 394 |
|
2021
Q3 | $6.23M | Sell |
32,988
-82
| -0.2% | -$15.5K | 0.05% | 341 |
|
2021
Q2 | $5.61M | Sell |
33,070
-428
| -1% | -$72.6K | 0.05% | 382 |
|
2021
Q1 | $4.73M | Buy |
33,498
+243
| +0.7% | +$34.3K | 0.04% | 423 |
|
2020
Q4 | $4.32M | Sell |
33,255
-1,683
| -5% | -$219K | 0.04% | 414 |
|
2020
Q3 | $5.09M | Buy |
34,938
+8,713
| +33% | +$1.27M | 0.05% | 328 |
|
2020
Q2 | $3.88M | Buy |
26,225
+568
| +2% | +$84.1K | 0.05% | 316 |
|
2020
Q1 | $2.79M | Buy |
+25,657
| New | +$2.79M | 0.05% | 393 |
|